Fact CheckerSign in

NCT04412863CompletedPhase 2

Study of VIR-2218 With or Without Pegylated Interferon Alpha-2a for Treatment of Chronic Hepatitis B Virus Infection

A Phase 1/2 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of VIR-2218 Alone or in Combination With Pegylated Interferon Alpha-2a

Source: ClinicalTrials.gov · Last updated 16 Apr 2026

Brief summary (registry, in English)

This is a phase 2 study in which subjects with chronic hepatitis B virus (HBV) infection will receive VIR-2218 alone or in combination with pegylated interferon alfa-2a and will be assessed for safety, tolerability, pharmacokinetics, and antiviral activity.

Status (registry)
Completed
Phase (registry)
Phase 2
Study type
Interventional
Enrollment
84 (actual)
First submitted
29 May 2020
Start date
3 Jul 2020
Primary completion date
25 Mar 2024
Lead sponsor
Vir Biotechnology, Inc.
Diseases
Hepatitis B
NCT number
NCT04412863

What you commit to

  • Study type: Interventional · Phase 2
  • Participants enrolled: 84
  • From 3 Jul 2020 to the primary completion date, 25 Mar 2024
  • 18 sites in 6 countries
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • History or evidence of drug or alcohol abuse
  • Any prior receipt of an interferon product

Other illness

  • Any clinically significant chronic or acute medical condition that makes the volunteer unsuitable for participation
  • History of intolerance to SC injection
  • History of chronic liver disease from any cause other than chronic HBV infection
  • History of hepatic decompensation

Other

  • Significant fibrosis or cirrhosis

Who the study is looking for

  • Male or female of ages 18 - 65
  • Chronic HBV infection for \>/= 6 months

Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (18)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Investigative Site
Coordinator of this site? Confirm its status
BirtinyaAustraliaUnknown status
Investigative Site
Coordinator of this site? Confirm its status
FitzroyAustraliaUnknown status
Investigative Site
Coordinator of this site? Confirm its status
Hong KongHong Kong SAR ChinaUnknown status
Investigative Site
Coordinator of this site? Confirm its status
BusanSouth KoreaUnknown status
Investigative Site
Coordinator of this site? Confirm its status
ChuncheonSouth KoreaUnknown status
Investigative Site
Coordinator of this site? Confirm its status
DaeguSouth KoreaUnknown status
Investigative Site
Coordinator of this site? Confirm its status
SeoulSouth KoreaUnknown status
Investigative Site
Coordinator of this site? Confirm its status
YangsanSouth KoreaUnknown status
Investigative Site
Coordinator of this site? Confirm its status
Batu CavesMalaysiaUnknown status
Investigative Site
Coordinator of this site? Confirm its status
KajangMalaysiaUnknown status
Investigative Site
Coordinator of this site? Confirm its status
Kuala LumpurMalaysiaUnknown status
Investigative Site
Coordinator of this site? Confirm its status
KuantanMalaysiaUnknown status
Investigative Site
Coordinator of this site? Confirm its status
AucklandNew ZealandUnknown status
Investigative Site
Coordinator of this site? Confirm its status
BangkokThailandUnknown status
Investigative Site
Coordinator of this site? Confirm its status
Chiang MaiThailandUnknown status
Investigative Site
Coordinator of this site? Confirm its status
Hat YaiThailandUnknown status
Investigative Site
Coordinator of this site? Confirm its status
Khlong LuangThailandUnknown status
Investigative Site
Coordinator of this site? Confirm its status
Khon KaenThailandUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.